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Background
Schizophrenia (SZ) is a disorder that is characterized by disordered
thinking, memory, and perception in its patients. Schizoaffective
disorder (SAD) is a separate disorder that features symptoms of
schizophrenia and mood disorders. Because of the overlap in
symptoms it is relatively easy to confuse schizoaffective disorder
and schizophrenia.
To be diagnosed with schizophrenia, patients must have at least two
of the characteristic symptoms for a significant portion of time
during a 1-month period and experience significant disturbance in
functioning:1
• delusions
• hallucinations
• disorganized speech
• grossly disorganized or catatonic behavior
• negative symptoms
To be diagnosed with schizoaffective disorder, patients must exhibit
the symptoms required for schizophrenia in addition to presenting
with a major mood episode.1
• elevated and depressed moods, with their associated
symptoms
Neither condition is preventable or curable, but various treatments
exist for symptomatic suppression. However there are differences in
how the two disorders are treated, so accurate diagnosing is
imperative to ensure patients receive the appropriate evidencebased treatment.

Purpose
• To understand how the diagnostic criteria on paper translates into
real clinical practice
• To develop interventions to improve the care of patients with
schizophrenia and schizoaffective disorder.

Methodology
1. Conduct semi-structured qualitative interviews with psychiatrists
to understand how they diagnosis and treat patients with
schizophrenia and schizoaffective disorders.
2. For every psychiatrist interviewed, complete chart reviews of five
of their patients with schizophrenia and schizoaffective disorder.
3. Compare the real-world diagnosis and treatment of these patients
with
information
gathered
from
the
psychiatrists’
conceptualization of these disorders to explore patterns and
trends associated with providing psychopharmaceutical care.

Results
Table 1: Patient Baseline Characteristics
Characteristic

SZ
n = 6 (%)

Gender
Female
Male
Race
Caucasian
African American
Hispanic
Other
Undefined
Age (yrs)
< 25
25-35
35-45
45-55
55-65
≥ 65
Alcohol Use
Never drank
Former drinker
Current drinker
Unknown
Illegal Drug Use
Never used
Former user
Current user
Unknown
Housing
Lives alone
Lives with family/friends
Lives in group home
Lives in homeless shelter
Prior Psych Hospitalizations
Two or less
Three - Four
Five or more
Unknown

SAD
n = 29 (%)

3 (50%)
3 (50%)

13 (44.8%)
16 (55.2%)

5 (83.3%)
0
0
0
1 (16.7%)

18 (62.1%)
4 (13.8%)
1 (3.4%)
1 (3.4%)
5 (17.2%)

0
0
0
2 (33.3%)
2 (33.3%)
2 (33.3%)

1 (3.4%)
5 (17.2%)
2 (6.9%)
8 (27.6%)
8 (27.6%)
5 (17.2%)

1 (16.7%)
0
1 (16.7%)
4 (66.7%)

11 (37.9%)
4 (13.8%)
6 (20.7%)
8 (27.6%)

1 (16.7%)
0
1 (16.7%)
4 (66.7%)

8 (27.6%)
4 (13.8%)
7 (24.1%)
10 (34.5%)

1 (16.7%)
1 (16.7%)
3 (50%)
1 (16.7%)

6 (20.7%)
7 (24.1%)
11 (37.9%)
5 (17.2%)

3 (50%)
1 (16.7%)
2 (33.3%)
0

6 (20.7%)
6 (20.7%)
16 (55.2%)
1 (3.4%)

Eight psychiatrists were actively recruited but only seven
psychiatrists were interviewed
Effective methods of improving adherence discussed by
psychiatrists

Formulation change
14%
Long-acting
injectable
36%
Programs (counseling,
psychoeducation)
21%

Table 2: Outcome Results
Criteria
Diagnosis
Total # of patients before admission
Total # of patients after admission
# of change in diagnosis
Treatment
Total # of antipsychotics before admission
Total # of antipsychotics after admission
Average # of antipsychotics per patient
Total # of mood stabilizers before admission
Total # of mood stabilizers after admission
Average # of mood stabilizers per patient
Net improvement in mental status exam
before vs. after hospitalization
None = 0
Minimal < 2
Moderate 2-4
Significant ≥ 5
Adherence
Total # of long-acting medications prescribed
at discharge
Total # of patients setup with outpatient
medical supervision at discharge

SZ
n = 6 (%)

SAD
n = 29 (%)

6 (100%)
4 (66.6%)
2 (33.3%)

29 (100%)
29 (100%)
0 (0%)

6
7
1.67
3
2
0.33
3.5

45
40
1.38
16
17
0.59
3.0

2 (33.6%)

9 (31%)

4 (66.6%)

21 (72.4%)

• No diagnosis changes from SAD, while still possibly changing SZ
to SAD, reflects how the psychiatrists conceptualized the
distinction between diagnosing these two conditions
• Majority of psychiatrists suggested SAD patients tend to have
more success from therapy, opposite of the greater net
improvement seen in SZ patients
• Overall decrease in pill burden after admission implies that
psychiatrists do work towards minimizing medications for patients
• Majority of the psychiatrists reported preferring single agents and
short-acting agents, unless adherence was compromised
• 72.4% of SAD patients and 66.6% of SZ patients received
adherence support, showing that psychiatrists helped more than
half of their patients receive these services because of their great
concern regarding continued patient adherence to therapy

Conclusion
Preliminary trends have been evident as we proceed with our data
analysis. The majority of psychiatrists did acknowledge a distinction
between the two conditions and this distinction is supported by their
diagnosing and treatment habits. However, they did not draw
distinctions when discussing the issue of adherence, as almost all of
them considered the lack of patient adherence as the main challenge
of treatment. Larger and more structured studies are needed to
further explore and confirm these findings.
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